Avidity Partners Management as of Dec. 31, 2019
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 33 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Baxter International (BAX) | 8.7 | $14M | 165k | 83.62 | |
Hca Holdings (HCA) | 5.8 | $9.3M | 63k | 147.81 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 5.5 | $8.8M | 40k | 218.95 | |
Abbvie (ABBV) | 5.2 | $8.3M | 94k | 88.54 | |
Mirati Therapeutics | 5.2 | $8.2M | 64k | 128.86 | |
Zimmer Holdings (ZBH) | 5.1 | $8.2M | 55k | 149.69 | |
Esperion Therapeutics (ESPR) | 4.9 | $7.8M | 130k | 59.63 | |
Edwards Lifesciences (EW) | 4.0 | $6.3M | 27k | 233.30 | |
Cigna Corp (CI) | 3.9 | $6.1M | 30k | 204.50 | |
Ascendis Pharma A S (ASND) | 3.7 | $5.9M | 42k | 139.12 | |
Axonics Modulation Technolog (AXNX) | 3.6 | $5.8M | 208k | 27.71 | |
Horizon Therapeutics | 3.4 | $5.4M | 150k | 36.20 | |
Nextcure (NXTC) | 3.3 | $5.2M | 93k | 56.33 | |
Catalent (CTLT) | 3.3 | $5.2M | 92k | 56.30 | |
Aurinia Pharmaceuticals (AUPH) | 3.0 | $4.7M | 232k | 20.26 | |
Dynavax Technologies (DVAX) | 2.8 | $4.5M | 780k | 5.72 | |
Abeona Therapeutics | 2.7 | $4.3M | 1.3M | 3.27 | |
Dex (DXCM) | 2.6 | $4.2M | 19k | 218.74 | |
Momenta Pharmaceuticals | 2.5 | $3.9M | 200k | 19.73 | |
Uniqure Nv (QURE) | 2.5 | $3.9M | 55k | 71.65 | |
Coherus Biosciences (CHRS) | 2.4 | $3.9M | 215k | 18.00 | |
Kadmon Hldgs | 2.4 | $3.8M | 830k | 4.53 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.3 | $3.7M | 180k | 20.58 | |
Neurocrine Biosciences (NBIX) | 2.2 | $3.5M | 33k | 107.48 | |
Immunomedics | 1.9 | $3.0M | 140k | 21.16 | |
EXACT Sciences Corporation (EXAS) | 1.8 | $2.9M | 31k | 92.48 | |
Neoleukin Therapeutics | 1.6 | $2.6M | 210k | 12.32 | |
ACADIA Pharmaceuticals (ACAD) | 1.5 | $2.3M | 54k | 42.78 | |
Madrigal Pharmaceuticals (MDGL) | 0.9 | $1.4M | 15k | 91.13 | |
Rocket Pharmaceuticals (RCKT) | 0.4 | $683k | 30k | 22.77 | |
Sunesis Pharmaceuticals Inc Ne | 0.3 | $473k | 1.4M | 0.34 | |
Aravive | 0.3 | $410k | 30k | 13.67 | |
Relmada Therapeutics (RLMD) | 0.2 | $390k | 10k | 39.00 |